Business
-
Almirall has announced that Invida Holdings has licensed the rights to market aclidinium bromide inhalers for the treatment of COPD in Australia and New Zealand. The deal covers Genuair DPIs with aclidinium alone and a… Read more . . .
-
Powder characterization specialist Freeman Technology has reached an agreement with distribution partner DKSH to expand into China. DKSH already distributes Freeman’s FT4 Powder Rheometer in Singapore, Malaysia, Thailand and Taiwan and will now distribute the… Read more . . .
-
Fresenius Kabi has announced the availability of 30 ml vials acetylcysteine inhalation solution, 20%, helping to alleviate a shortage of the product in the US. The company is marketing the inhalation solution in the US… Read more . . .
-
The US Patent and Trade Office has awarded Aegis Therapeutics US Patent No. 8,268,791 for “Alkylglycoside compositions for drug administration.” The company is highlighting the patent’s coverage of fast-acting intranasal triptan formulations for the treatment… Read more . . .
-
In order to meet rising demand for its GMP nasal spray testing services, Melbourn Scientific has dedicated a laboratory to analysis of droplet size, particle characterization, spray pattern, plume geometry, and device performance testing. The… Read more . . .
-
OINDP testing specialist Proveris Scientific UK Limited, a wholly owned subsidiary of Proveris Scientific Corporation, is expanding its operations to support increasing business in Asia and Europe. In addition to hiring a new field service… Read more . . .
-
Boehringer Ingelheim has launched the Combivent Respimat ipratropium bromide/albuterol soft mist inhaler for the treatment of COPD in the United States. The Combivent Respimat includes enough doses for 30 days, compared to the Combivent MDI,… Read more . . .
-
Cystic Fibrosis Foundation Therapeutics (CFFT) will provide up to $1.4 million to Pulmatrix to support Phase 1b trials of Pulmatrix’s lead candidate, PUR118, for the treatment of CF. The collaboration between the nonprofit affiliate of… Read more . . .
-
Teva has filed a lawsuit in the US District Court for the District of Delaware against Perrigo and Catalent after Perrigo filed an ANDA for a generic version of Teva’s ProAir HFA albuterol sulfate MDI.… Read more . . .
-
The FDA has approved a generic equivalent to Meda’s Astepro, an azelastine nasal spray, 0.1876MG, manufactured by Apotex. Meda filed a patent infringement suit in January 2012 after Apotex submitted its ANDA. The two companies… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.